AMBER SHEPARD: Open Payments
NPI 1104309129 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,782 in 130 payments from 31 companies in 2025. Trend: 2023 $2,781 · 2024 $2,480 · 2025 $2,782
Food & beverage: $2,782
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $256 |
| Incyte Corporation | 10 | $236 |
| E.R. Squibb & Sons, L.L.C. | 13 | $219 |
| Merck Sharp & Dohme LLC | 7 | $174 |
| Celgene Corporation | 12 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $162 |
| Janssen Biotech, Inc. | 7 | $156 |
| Regeneron Healthcare Solutions, Inc. | 5 | $131 |
| PFIZER INC. | 5 | $110 |
| Lilly USA, LLC | 5 | $97 |
Products named: OPDIVO, KEYTRUDA, MONJUVI, REBLOZYL, KISQALI, LYNOZYFIC, VERZENIO, Fabhalta.
Industry payments across TN — which companies pay providers there.
